LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 100 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,195 | -37.4% | 31,372 | +31.5% | 0.00% | – |
| Q2 2023 | $54,626 | +2.8% | 23,854 | +9.1% | 0.00% | – |
| Q1 2023 | $53,151 | +30.6% | 21,873 | +2.7% | 0.00% | – |
| Q4 2022 | $40,685 | -15.2% | 21,301 | +6.7% | 0.00% | – |
| Q3 2022 | $48,000 | +60.0% | 19,957 | +23.1% | 0.00% | – |
| Q2 2022 | $30,000 | -11.8% | 16,216 | +0.7% | 0.00% | – |
| Q1 2022 | $34,000 | -44.3% | 16,100 | +3.5% | 0.00% | – |
| Q4 2021 | $61,000 | -19.7% | 15,554 | -1.1% | 0.00% | -100.0% |
| Q3 2021 | $76,000 | +5.6% | 15,732 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $72,000 | +227.3% | 15,696 | +39.8% | 0.00% | – |
| Q1 2020 | $22,000 | – | 11,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |